IRIS UniCatt

De Candia, Erica
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.008
AS - Asia 2.710
EU - Europa 2.587
SA - Sud America 516
Continente sconosciuto - Info sul continente non disponibili 146
AF - Africa 78
OC - Oceania 17
Totale 10.062
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.891
SG - Singapore 1.271
CN - Cina 561
IT - Italia 529
DE - Germania 449
BR - Brasile 439
PL - Polonia 382
SE - Svezia 381
VN - Vietnam 246
FR - Francia 178
UA - Ucraina 142
IE - Irlanda 137
GB - Regno Unito 111
IN - India 102
BD - Bangladesh 83
ID - Indonesia 82
JP - Giappone 80
FI - Finlandia 79
CA - Canada 64
HK - Hong Kong 59
RU - Federazione Russa 51
MX - Messico 38
NL - Olanda 34
AR - Argentina 33
IQ - Iraq 32
TR - Turchia 32
AT - Austria 23
PK - Pakistan 21
IR - Iran 20
ZA - Sudafrica 20
BE - Belgio 19
KR - Corea 17
AU - Australia 16
EG - Egitto 16
EC - Ecuador 15
ES - Italia 15
JO - Giordania 14
HU - Ungheria 12
MA - Marocco 12
UZ - Uzbekistan 12
CH - Svizzera 10
MY - Malesia 9
RO - Romania 9
IL - Israele 8
PH - Filippine 8
SA - Arabia Saudita 8
VE - Venezuela 8
KE - Kenya 7
TN - Tunisia 7
AE - Emirati Arabi Uniti 6
BH - Bahrain 5
CL - Cile 5
LB - Libano 5
NP - Nepal 5
PY - Paraguay 5
CI - Costa d'Avorio 4
CZ - Repubblica Ceca 4
LT - Lituania 4
MK - Macedonia 4
SY - Repubblica araba siriana 4
UY - Uruguay 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BO - Bolivia 3
DO - Repubblica Dominicana 3
ET - Etiopia 3
TW - Taiwan 3
AL - Albania 2
AZ - Azerbaigian 2
BG - Bulgaria 2
CO - Colombia 2
CR - Costa Rica 2
DZ - Algeria 2
GE - Georgia 2
GT - Guatemala 2
JM - Giamaica 2
KW - Kuwait 2
MN - Mongolia 2
NG - Nigeria 2
PE - Perù 2
PS - Palestinian Territory 2
AM - Armenia 1
BB - Barbados 1
BN - Brunei Darussalam 1
BZ - Belize 1
CG - Congo 1
CY - Cipro 1
DK - Danimarca 1
EE - Estonia 1
GA - Gabon 1
GI - Gibilterra 1
GR - Grecia 1
HR - Croazia 1
KZ - Kazakistan 1
LC - Santa Lucia 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LV - Lettonia 1
MD - Moldavia 1
MG - Madagascar 1
ML - Mali 1
Totale 9.910
Salva come PNG Salva come JPEG
Città #
Singapore 756
Ashburn 462
Warsaw 374
San Jose 372
Chandler 333
Dublin 131
Beijing 118
Los Angeles 117
Fairfield 106
New York 99
Rome 99
Wilmington 91
San Mateo 90
Ho Chi Minh City 82
Jakarta 72
Jacksonville 71
Council Bluffs 68
Tokyo 68
Hanoi 66
Lauterbourg 66
Woodbridge 62
Hefei 60
Milan 60
Ann Arbor 59
Nanjing 59
Munich 56
Hong Kong 54
Seattle 54
Boston 51
Houston 50
Buffalo 48
Chicago 42
Dallas 42
Marseille 42
Frankfurt am Main 39
Boardman 37
Moscow 36
Princeton 36
São Paulo 36
Dearborn 33
Santa Clara 32
The Dalles 32
Cambridge 28
Cattolica 28
Redwood City 28
Helsinki 25
Hyderabad 23
London 23
Lawrence 20
Nuremberg 20
Atlanta 19
Denver 18
Nanchang 18
Rio de Janeiro 18
San Francisco 17
Toronto 17
Brussels 16
Seoul 16
Tukwila 16
Da Nang 14
Shanghai 14
Turku 14
Augusta 13
Bologna 13
Hangzhou 13
Kent 13
Montreal 13
Phoenix 13
Redmond 13
Amman 12
Andover 12
Curitiba 12
Guangzhou 12
Lappeenranta 12
Nürnberg 12
Pune 12
St Louis 12
Chennai 11
Izmir 11
Naples 11
Norwalk 11
San Diego 11
Baghdad 10
Bari 10
Bremen 10
Brooklyn 10
Budapest 10
Guarulhos 10
Mountain View 10
Tashkent 10
Vienna 10
Washington 10
Zhengzhou 10
Brasília 9
Johannesburg 9
Mexico City 9
Paris 9
Verona 9
Belo Horizonte 8
Hebei 8
Totale 5.466
Salva come PNG Salva come JPEG
Nome #
Abnormal proplatelet formation and emperipolesis in cultured human megakaryocytes from gray platelet syndrome patients 466
Correlation between platelet phenotype and NBEAL2 genotype in patients with congenital thrombocytopenia and α-granule deficiency 325
Megakaryocytic emperipolesis and platelet function abnormalities in five patients with gray platelet syndrome 300
Bleeding risk of surgery and its prevention in patients with inherited platelet disorders. The Surgery in Platelet disorders And Therapeutic Approach (SPATA) study 279
Thromboelastography clot strength profiles and effect of systemic anticoagulation in COVID-19 acute respiratory distress syndrome: a prospective, observational study 227
Eltrombopag for the treatment of inherited thrombocytopenias: a phase 2 clinical trial 219
Data on the application of early coagulation support protocol in the management of major trauma patients 204
Nonalcoholic fatty liver disease (NAFLD) severity is associated to a nonhemostatic contribution and proinflammatory phenotype of platelets 189
Murine platelet production is suppressed by S1P release in the hematopoietic niche, not facilitated by blood S1P sensing. 176
Carbamazepine interaction with direct oral anticoagulants: help from the laboratory for the personalized management of oral anticoagulant therapy 174
Noncanonical type 2B von Willebrand disease associated with mutations in the VWF D9D3 and D4 domains 173
Effect of fibrinogen concentration on the velocity of platelet aggregation. 167
COVID-19 and haemostasis: a position paper from Italian Society on Thrombosis and Haemostasis (SISET) 165
Platelets and Neurodegenerative Diseases: Current Knowledge and Future Perspectives 161
Safety of antithrombotic therapy in subjects with hereditary hemorrhagic telangiectasia: prospective data from a multidisciplinary working group 158
Heparin induced thrombocytopenia: Position paper from the Italian Society on Thrombosis and Haemostasis (SISET) 158
Nonalcoholic fatty liver disease (NAFLD) severity is associated to a nonhemostatic contribution and proinflammatory phenotype of platelets 157
Functional role of protease activated receptors in vascular biology 156
Patients with antiphospholipid syndrome and a first venous or arterial thrombotic event: clinical characteristics, antibody profiles and estimate of the risk of recurrence 154
Autoimmune disorders of platelet function: systematic review of cases of acquired Glanzmann thrombasthenia and acquired delta storage pool disease 152
Does chronic oral anticoagulation reduce in-hospital mortality among COVID-19 older patients? 145
Structural and funtional mapping of the thrombin domain involved in the binding to the platelet glycoprotein Ib 141
Evaluation of Novel Guanidino-Containing Isonipecotamide Inhibitors of Blood Coagulation Factors against SARS-CoV-2 Virus Infection 140
MORE EARLY BLEEDS ASSOCIATED WITH HIGH BASELINE DIRECT ORAL ANTICOAGULANT LEVELS IN ATRIAL FIBRILLATION: THE MAS STUDY 140
Lymph node blast crisis in chronic myeloid leukemia mimicking T-immunoblastic lymphoma. 136
Mechanisms of platelet activation by thrombin: a short history 135
Detection of Platelet-Activating Antibodies Associated with Vaccine-Induced Thrombotic Thrombocytopenia by Flow Cytometry: An Italian Experience 134
Effects of unfractionated and low molecular weight heparins on platelet thromboxane biosynthesis "in vivo" 132
Hemophilia A and von Willebrand deficiency: therapeutic implications 131
Direct oral anticoagulants and therapeutic adherence: do not let your guard down 131
Consensus statements on vaccination in patients with haemophilia—Results from the Italian haemophilia and vaccinations (HEVA) project 130
MYH9-Related Disease: A Novel Prognostic Model to Predict the Clinical Evolution of the Disease Based on Genotype-Phenotype Correlations 128
Impact of Gut Microbiota on Obesity, Diabetes, and Cardiovascular Disease Risk 124
Early coagulation support protocol: A valid approach in real-life management of major trauma patients. Results from two Italian centres 124
Carbamazepine interaction with direct oral anticoagulants: help from the laboratory for the personalized management of oral anticoagulant therapy 124
Defective platelet responsiveness to thrombin and protease-activated receptors agonists in a novel case of gray platelet syndrome: correlation between the platelet defect and the alpha-granule content in the patient and four relatives 123
Antithrombotic prophylaxis for surgery-associated venous thromboembolism risk in patients with inherited platelet disorders. The SPATA-DVT Study 122
Safety and effectiveness of oral anticoagulants in patients with atrial fibrillation and stage 4 chronic kidney disease: a real-world experience 121
Thrombotic events associated with low baseline direct oral anticoagulant levels in atrial fibrillations: the MAS study 119
Increased platelet-fibrinogen affinity in patients with myeloproliferative disorders. 119
D-dimer and reduced-dose apixaban for extended treatment after unprovoked venous thromboembolism: the Apidulcis study 116
Thrombin interaction with platelet GpIB: role of the heparin binding domain. 113
Thrombin-thrombomodulin interaction: energetics and potential role of water as an allosteric effector. 113
Allosteric equilibria in the binding reaction of fibrinogen to platelets. 113
Portal vein thrombosis occurrence in a cirrhotic patient during treatment with rivaroxaban 108
Extended coagulation profile of children with Long Covid: a prospective study 107
The ISTH bleeding assessment tool as predictor of bleeding events in inherited platelet disorders: Communication from the ISTH SSC Subcommittee on Platelet Physiology 107
Gut Microbiome Diversity and Composition Correlates With Time in the Therapeutic Range in Patients on Warfarin Treatment: A Pilot Study 107
Hepatocellular carcinoma complicating liver cirrhosis in type IIIa glycogen storage disease. 105
Association of laboratory test results with the bleeding history in patients with inherited platelet function disorders (the Bleeding Assesment Tool - LABoratory tests substudy): communication from the Platelet Physiology ISTH-SSC 104
Binding of human alpha-thrombin to platelet GpIb: energetics and functional effects. 104
Ibrutinib does not affect ristocetin-induced platelet aggregation evaluated by light transmission aggregometry in chronic lymphocytic leukemia patients 104
Novel manifestations of immune dysregulation and granule defects in gray platelet syndrome 101
NETosis in arterial and venous thrombosis: a one size fits all mechanism? 99
Rituximab for treatment of autoimmune acquired platelet function disorders: description of two cases of acquired Glanzmann thrombasthenia and one case of acquired delta storage pool disease 98
Circulating Activated Platelets in Children With Long Covid: A Case-Controlled Preliminary Observation 94
Analysis of 339 pregnancies in 181 women with 13 different forms of inherited thrombocytopenia 94
INHIBITION OF FIBRINOGEN BINDING TO HUMAN-PLATELETS BY BLOCKAGE OF NA+/H+ EXCHANGE. 91
MYH9-Related Disease: A Novel Prognostic Model to Predict the Clinical Evolution of the Disease Based on Genotype-Phenotype Correlations 90
Platelet diameters in inherited thrombocytopenias: analysis of 376 patients with all known disorders 90
Bleeding and thrombotic events in a patient with lupus anticoagulant-associated hypoprothrombinemia and antiphospholipid antibody syndromes: managing hemostasis between Scylla and Charybdis 89
Megakaryocytic emperipolesis and platelet function abnormalities in five patients with gray platelet syndrome 89
Association of human leucocyte antigen loci with vaccine-induced immune thrombotic thrombocytopenia: Potential role of the interaction between platelet factor 4-derived peptides and MHC-II 86
Cell Surface Platelet Tissue Factor Expression: Regulation by P2Y12 and Link to Residual Platelet Reactivity 80
Management of bleeding and of invasive procedures in patients with platelet disorders and/or thrombocytopenia:Guidelines of the Italian Society for Haemostasis and Thrombosis (SISET) 80
Validation of the ISTH/SSC bleeding assessment tool for inherited platelet disorders: A communication from the Platelet Physiology SSC 78
Defective platelet responsiveness to thrombin and protease-activated receptors agonists in a novel case of gray platelet syndrome: correlation between the platelet defect and the alpha-granule content in the patient and four relatives 78
Why the disorder induced by GATA1 Arg216Gln mutation should be called "X-linked thrombocytopenia with thalassemia" rather than "X-linked gray platelet syndrome 76
Binding of thrombin to glycoprotein Ib accelerates the hydrolysis of Par-1 on intact platelets 72
COVID-19 pandemic affects the ability of negative D-dimer to identify venous thromboembolism patients at low risk of recurrence: insights from the Apidulcis study 71
Protective effect of oral anticoagulant drugs in atrial fibrillation patients admitted for COVID-19: Results from the CORIST study 71
Prevalence and significance of anti-prothrombin (aPT) antibodies in patients with Lupus Anticoagulant (LA). 70
Atrial Fibrillation, Heart Failure Phenotypes, and Mortality Risk in the Nationwide START Registry: A Propensity Score Matching Analysis 56
Long-term left ventricular thrombosis resolution in patients receiving vitamin k antagonists: a multicenter observational study 44
Increased platelet-fibrinogen affinity in patients with myeloproliferative disorders 42
Impact of the 2023 ACR/EULAR Classification Criteria on START2 Antiphospholipid Registry 40
Early Platelet Dysfunction in Sepsis: An ICU Pilot Study 23
PO-54 - Clinical and laboratory characterization of platelet dysfunction caused by ibrutinib treatment in patients with chronic lymphocytic leukemia 18
Real-world use of direct oral anticoagulants in atrial fibrillation patients with moderate/severe chronic kidney disease: a propensity score matched analysis from the START registry 17
Thrombotic Risk and Coagulation Imbalance in Cirrhosis and Hepatocellular Carcinoma: Clinical Implications and Management 17
Effectiveness of direct oral anticoagulants for all-cause mortality and cardiovascular events in overweight and obese patients with atrial fibrillation: Insight from the nationwide START registry 15
Drug-related hepatotoxicity risk in elderly patients with atrial fibrillation: insights from the nationwide Italian START registry 14
Thrombocytopenia in carriers and patients with antiphospholipid syndrome: insights from the nationwide START-APS registry 9
Autoimmune disorders of platelet function: systematic review of cases of acquired Glanzmann thrombasthenia and acquired delta storage pool disease 7
Multiple arterial thrombosis in a 33-year-old woman with anasarca, systemic lupus erythematosus, and acquired coagulopathy 3
Totale 10.062
Salva come PNG Salva come JPEG
Categoria #
all - tutte 41.455
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 41.455
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022614 0 82 22 39 34 18 18 111 23 39 112 116
2022/20231.048 141 135 71 141 85 126 74 84 129 12 33 17
2023/2024657 19 161 27 34 28 70 48 16 12 26 52 164
2024/20251.235 24 32 113 64 65 46 42 49 172 133 302 193
2025/20263.845 527 155 225 391 638 205 659 173 225 251 204 192
2026/2027745 272 473 0 0 0 0 0 0 0 0 0 0
Totale 10.062